Leerink Partnrs Issues Negative Outlook for INSP Earnings

Inspire Medical Systems, Inc. (NYSE:INSP) – Investment analysts at Leerink Partnrs decreased their Q4 2025 earnings estimates for Inspire Medical Systems in a report issued on Monday, November 3rd. Leerink Partnrs analyst M. Kratky now forecasts that the company will post earnings of $0.67 per share for the quarter, down from their previous estimate of $0.71. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $2.16 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ FY2028 earnings at $3.33 EPS.

Several other research firms have also commented on INSP. Lake Street Capital set a $150.00 price objective on shares of Inspire Medical Systems and gave the stock a “buy” rating in a research note on Tuesday, August 5th. UBS Group set a $89.00 price objective on shares of Inspire Medical Systems and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Evercore ISI dropped their price objective on shares of Inspire Medical Systems from $150.00 to $125.00 and set an “outperform” rating for the company in a research note on Tuesday, October 7th. Truist Financial reaffirmed a “hold” rating and set a $84.00 price objective (down from $90.00) on shares of Inspire Medical Systems in a research note on Tuesday. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Inspire Medical Systems from $110.00 to $82.00 and set a “neutral” rating for the company in a research note on Tuesday. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $133.88.

Inspire Medical Systems Stock Performance

Shares of INSP opened at $82.78 on Wednesday. The company’s fifty day moving average is $80.04 and its 200 day moving average is $112.23. Inspire Medical Systems has a fifty-two week low of $70.77 and a fifty-two week high of $216.01. The stock has a market capitalization of $2.41 billion, a PE ratio of 56.31, a P/E/G ratio of 3.00 and a beta of 1.14.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.53. Inspire Medical Systems had a net margin of 5.05% and a return on equity of 9.41%. The company had revenue of $224.50 million for the quarter, compared to analysts’ expectations of $220.39 million. During the same quarter in the previous year, the business posted $0.60 earnings per share. Inspire Medical Systems’s quarterly revenue was up 10.5% on a year-over-year basis.

Inspire Medical Systems announced that its board has approved a stock buyback plan on Monday, August 11th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the company to purchase up to 8.6% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s board believes its stock is undervalued.

Insider Activity

In other news, CFO Richard Buchholz sold 11,000 shares of the business’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $93.39, for a total transaction of $1,027,290.00. Following the completion of the sale, the chief financial officer directly owned 44,867 shares of the company’s stock, valued at approximately $4,190,129.13. The trade was a 19.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 4.10% of the company’s stock.

Institutional Trading of Inspire Medical Systems

Hedge funds have recently added to or reduced their stakes in the business. Manning & Napier Advisors LLC purchased a new stake in shares of Inspire Medical Systems during the third quarter valued at about $32,000. Quarry LP lifted its position in shares of Inspire Medical Systems by 2,127.3% during the first quarter. Quarry LP now owns 245 shares of the company’s stock valued at $39,000 after buying an additional 234 shares during the last quarter. Banque Transatlantique SA purchased a new stake in shares of Inspire Medical Systems during the first quarter valued at about $46,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Inspire Medical Systems during the third quarter valued at about $49,000. Finally, Daiwa Securities Group Inc. lifted its position in shares of Inspire Medical Systems by 38.7% during the second quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock valued at $60,000 after buying an additional 130 shares during the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.